Clinical Trial Update: Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of SAR443122 in adults with ulcerative colitis is active/not recruiting, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SAR443122

Snippet

Sponsor: Sanofi | Conditions: Colitis Ulcerative | Phase 2 | Status: ACTIVE_NOT_RECRUITING